Adiponectin Levels Differentiate Metabolically Healthy vs Unhealthy Among Obese and Nonobese White Individuals

被引:95
作者
Ahl, Scott [1 ]
Guenther, Mitchell [1 ]
Zhao, Shi [2 ]
James, Roland [1 ]
Marks, Jacqueline [1 ]
Szabo, Aniko [2 ]
Kidambi, Srividya [1 ]
机构
[1] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Inst Hlth & Soc, Milwaukee, WI 53226 USA
基金
美国国家卫生研究院;
关键词
SUBCUTANEOUS ADIPOSE-TISSUE; INSULIN-RESISTANCE; ENERGY-METABOLISM; ENDOCRINE ORGAN; PLASMA-PROTEIN; RISK-FACTORS; ADIPOCYTE; FAT; ASSOCIATION; DISEASE;
D O I
10.1210/jc.2015-2765
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Adiponectin levels (ADPN) are lower in individuals with central obesity and cardiometabolic diseases. Conversely, studies have shown paradoxical hyperadiponectinemia (HA) in metabolically healthy obese (MHO) individuals of non-European descent. Moreover, individuals with higher sc to visceral adipose tissue (ie, higher peripheral adiposity) distribution have higher ADPNs. However, it is not known whether metabolically healthy individuals have predominantly peripheral adiposity along with higher ADPNs. Objective: This study aimed to evaluate the association of ADPN and adiposity distribution with metabolic health in white individuals. Design and Setting: This was a cross-sectional study of members of "Take Off Pounds Sensibly" weight loss club and their relatives. Participants: We recruited 2486 (72% women, 61% obese) individuals. They were defined as metabolically healthy by absence of hypertension, diabetes, and dyslipidemia; and they were further classified into metabolically healthy nonobese (MHNO), metabolically unhealthy nonobese (MUNO), metabolically healthy obese (MHO), and metabolically unhealthy obese (MUO). Waist-to-hip ratios (WHRs) were used as markers of adiposity distribution. Insulin resistance was measured using homeostasis model assessment. Results: Among the four groups, MHNO had the lowest WHRs (higher peripheral adiposity) and highest ADPN, and MUO had highest WHRs (higher central adiposity) and lowest ADPN (P < .001). Among both nonobese and obese, metabolically healthy individuals had higher ADPN than metabolically unhealthy individuals (P < .05) after adjustment for age, sex, and body mass index. MHNO also had lower WHRs compared with MUNO (P < .01). Although WHRs were lower among MHO compared with MUO, the difference was not significant. In addition, nonobese and obese individuals with HA (defined using sex-specific cutoffs) had lower homeostasis model assessment and dyslipidemia compared with individuals without HA. Conclusions: Higher ADPN and lower WHRs (higher peripheral adiposity) are associated with better metabolic health in both nonobese and obese white individuals. These results suggest that ADPN and peripheral adiposity play a key role in determining the metabolic health independent of body mass index.
引用
收藏
页码:4172 / 4180
页数:9
相关论文
共 46 条
[1]   High adiponectin concentrations are associated with the metabolically healthy obese phenotype [J].
Aguilar-Salinas, Carlos A. ;
Garcia Garcia, Eduardo ;
Robles, Lorena ;
Riano, Daniela ;
Georgina Ruiz-Gomez, Doris ;
Cristina Garcia-Ulloa, Ana ;
Melgarejo, Marco A. ;
Zamora, Margarita ;
Guillen-Pineda, Luz E. ;
Mehta, Roopa ;
Canizales-Quinteros, Samuel ;
Tusie Luna, Ma Teresa ;
Gomez-Perez, Francisco J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10) :4075-4079
[2]   Adipose tissue as an endocrine organ [J].
Ahima, RS ;
Flier, JS .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (08) :327-332
[3]   Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Maeda, K ;
Kuriyama, H ;
Okamoto, Y ;
Kumada, M ;
Hotta, K ;
Nishida, M ;
Takahashi, M ;
Nakamura, T ;
Shimomura, I ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
CIRCULATION, 2002, 105 (24) :2893-2898
[4]   Not all fat is alike [J].
Arner, P .
LANCET, 1998, 351 (9112) :1301-1302
[5]   The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases [J].
Balistreri, Carmela Rita ;
Caruso, Calogero ;
Candore, Giuseppina .
MEDIATORS OF INFLAMMATION, 2010, 2010
[6]   ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism [J].
Berg, AH ;
Combs, TP ;
Scherer, PE .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (02) :84-89
[7]   Opposing effects of adiponectin receptors 1 and 2 on energy metabolism [J].
Bjursell, Mikael ;
Ahnmark, Andrea ;
Bohlooly-Y, Mohammad ;
William-Olsson, Lena ;
Rhedin, Magdalena ;
Peng, Xiao-Rong ;
Ploj, Karolina ;
Gerdin, Anna-Karin ;
Arnerup, Gunnel ;
Elmgren, Anders ;
Berg, Anna-Lena ;
Oscarsson, Jan ;
Linden, Daniel .
DIABETES, 2007, 56 (03) :583-593
[8]   Adipose Tissue Dysregulation in Patients with Metabolic Syndrome [J].
Bremer, Andrew A. ;
Devaraj, Sridevi ;
Afify, Alaa ;
Jialal, Ishwarlal .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (11) :E1782-E1788
[9]  
Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158
[10]   The "New Deadly Quartet" for Cardiovascular Disease in the 21st Century: Obesity, Metabolic Syndrome, Inflammation and Climate Change: How Does Statin Therapy Fit into this Equation? [J].
Clearfield, Michael ;
Pearce, Melissa ;
Nibbe, Yasmin ;
Crotty, David ;
Wagner, Alesia .
CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (01)